Year-end review shows 23 new drugs approved, 14 important biologic licensing actions taken by FDA.
D008004:Licensure; D004364:Pharmaceutical Preparations; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations